| scholarly article | Q13442814 |
| P50 | author | Jeremy Farrar | Q15967402 |
| Tran Tinh Hien | Q30004272 | ||
| John Wain | Q37611197 | ||
| Christopher M Parry | Q91368884 | ||
| Phan Van Be Bay | Q114418052 | ||
| P2093 | author name string | Le Thi Phuong | |
| Mai Ngoc Lanh | |||
| Le Thanh Tung | |||
| Nguyen Thi Hong Tham | |||
| Vo Anh Ho | |||
| P2860 | cites work | Fluoroquinolone resistance in Salmonella Typhi | Q24679828 |
| Typhoid fever | Q28216285 | ||
| The global burden of typhoid fever | Q29619215 | ||
| Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever | Q31140106 | ||
| Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance | Q33670230 | ||
| Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever | Q33756339 | ||
| Intracellular activity of azithromycin against bacterial enteric pathogens | Q33757644 | ||
| Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi | Q33769931 | ||
| A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group | Q33856314 | ||
| Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance | Q33976948 | ||
| Failure of short-course ceftriaxone chemotherapy for multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan | Q33978826 | ||
| A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever | Q33979999 | ||
| Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children | Q34111805 | ||
| Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever | Q34341442 | ||
| Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin | Q34786576 | ||
| Effects on growth of single short courses of fluoroquinolones | Q34798843 | ||
| The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. | Q35770768 | ||
| Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients | Q35814807 | ||
| Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever | Q38906775 | ||
| Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi | Q40534173 | ||
| Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents | Q40537787 | ||
| Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae | Q40556003 | ||
| In vitro effects of azithromycin on Salmonella typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula | Q40605769 | ||
| Typhoid fever, ciprofloxacin and growth in young children | Q40607362 | ||
| Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children | Q40612317 | ||
| Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise | Q40621202 | ||
| Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India | Q40633386 | ||
| A highly ceftriaxone-resistant Salmonella typhi in Bangladesh | Q40639739 | ||
| Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment | Q40642659 | ||
| Is it time to change fluoroquinolone breakpoints for Salmonella spp.? | Q42858215 | ||
| Intermediate susceptibility to ciprofloxacin in Salmonella typhi strains in India | Q43834572 | ||
| Enteric fever in Mumbai, India: the good news and the bad news | Q50105472 | ||
| Typhoid and paratyphoid fever | Q57194898 | ||
| The pharmacokinetics of azithromycin in human serum and tissues | Q68448985 | ||
| In-vitro concentration of azithromycin in human phagocytic cells | Q70473491 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | typhoid fever | Q83319 |
| azithromycin | Q165399 | ||
| levofloxacin | Q424193 | ||
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 819-825 | |
| P577 | publication date | 2006-12-04 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever | |
| P478 | volume | 51 |
| Q37506861 | A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis |
| Q37340441 | A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned |
| Q28472731 | A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam |
| Q50010114 | A novel role for antibiotic resistance plasmids in facilitating Salmonella adaptation to non-host environments. |
| Q33565502 | A study of antibiogram of Salmonella enterica serovar Typhi isolates from Pondicherry, India |
| Q36595474 | Antibiotic binding of STY3178, a yfdX protein from Salmonella Typhi |
| Q33301096 | Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones |
| Q35191369 | Antimicrobial susceptibility to azithromycin among Salmonella enterica isolates from the United States |
| Q28484350 | Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults |
| Q24236348 | Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever) |
| Q24241024 | Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever) |
| Q93087971 | Azithromycin resistance mechanisms in typhoidal salmonellae in India: A 25 years analysis |
| Q34468258 | Case report: failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A. |
| Q35997526 | Ciprofloxacin-resistant Salmonella enterica Serotype Typhi, United States, 1999-2008. |
| Q35385211 | Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A |
| Q41928349 | Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial |
| Q42958161 | Conducting randomized controlled trials for the treatment of enteric Fever |
| Q64899527 | Current antibiotic use in the treatment of enteric fever in children. |
| Q34380025 | Development of Vi conjugate - a new generation of typhoid vaccine |
| Q35904279 | Diarrhoeagenic Escherichia coli in mother-child Pairs in Ile-Ife, South Western Nigeria |
| Q92392703 | Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis |
| Q37089532 | Effects of Fluoroquinolones and Azithromycin on Biofilm Formation of Stenotrophomonas maltophilia |
| Q40325642 | Efficacy and safety of azithromycin for uncomplicated typhoid fever: an open label non-comparative study |
| Q28479213 | Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid |
| Q42540420 | Emergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, India |
| Q38993278 | Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin |
| Q28084595 | Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections |
| Q55061015 | Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts. |
| Q90135534 | Expression of a novel class of bacterial Ig-like proteins is required for IncHI plasmid conjugation |
| Q37733267 | Failure of oral antibiotic therapy, including azithromycin, in the treatment of a recurrent breast abscess caused by Salmonella enterica serotype Paratyphi A. |
| Q24236124 | Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) |
| Q24241438 | Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever) |
| Q40326477 | Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial |
| Q35055415 | Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial |
| Q30983976 | High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children |
| Q34045279 | In vitro activity of azithromycin against nontyphoidal Salmonella enterica |
| Q38023251 | In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards |
| Q34108754 | In vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B. |
| Q33428610 | Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travellers: an 18-year experience |
| Q60053985 | Modelling the cost-effectiveness of a rapid diagnostic test (IgMFA) for uncomplicated typhoid fever in Cambodia |
| Q61811525 | Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities |
| Q42719211 | Multidrug-resistant typhoid fever outbreak in travelers returning from Bangladesh |
| Q55026157 | Open label comparative trial of mono versus dual antibiotic therapy for Typhoid Fever in adults. |
| Q37444220 | Optimising Antibiotic Usage to Treat Bacterial Infections. |
| Q26851716 | Paratyphoid fever: splicing the global analyses |
| Q50952547 | Pharmacokinetics, urinary excretion and plasma protein binding of ofloxacin in water buffalo calves (Bubalus bubalis). |
| Q33666510 | Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine |
| Q37798457 | Quinolone and cephalosporin resistance in enteric fever |
| Q40321624 | Risk factors associated with typhoid fever in children aged 2-16 years in Karachi, Pakistan |
| Q37583008 | Risk factors for the development of severe typhoid fever in Vietnam |
| Q37664510 | Salmonella subtypes with increased MICs for azithromycin in travelers returned to The Netherlands |
| Q27486641 | Strategies to Reduce Mortality from Bacterial Sepsis in Adults in Developing Countries |
| Q34309550 | Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones |
| Q40396446 | The expanding spectrum of disease due to salmonella: an international perspective |
| Q33945463 | The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy |
| Q39301438 | The sensitivity of real-time PCR amplification targeting invasive Salmonella serovars in biological specimens |
| Q55465441 | The treatment of enteric fever. |
| Q92251974 | Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model |
| Q38070846 | Typhoid Fever in an inner city hospital: a 5-year retrospective review |
| Q57136472 | Typhoid and paratyphoid fever: a call to action |
| Q90600888 | Typhoid fever: issues in laboratory detection, treatment options & concerns in management in developing countries |
Search more.